Study will take place at Imperial College London
Category: Uncategorized
New administration option for relapsing-remitting MS patients
Updated Date: Tue, 29 Dec 2020 00:00:00 EST
Updated Date: Tue, 29 Dec 2020 00:00:00 EST
Updated Date: Tue, 29 Dec 2020 00:00:00 EST
Updated Date: Tue, 29 Dec 2020 00:00:00 EST
Updated Date: Tue, 29 Dec 2020 00:00:00 EST
Missouri’s Nostrum Labs pulls more metformin over carcinogen concerns fkansteiner Tue, 01/05/2021 – 13:04
Moderna dials up low-end COVID-19 vaccine supply estimate, setting sights on 1B doses in 2021 fkansteiner Mon, 01/04/2021 […]
Shanghai Pharma maps out $1.18B industrial park in hometown biopharma hub fkansteiner Tue, 01/05/2021 – 07:58